The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 62 | 15.4x | 20.1x | Near average | |
Growth | 37 | 1.8% | 5.6% | Near average | |
Quality | 67 | 16.7% | 7.6% | Above average | |
Safety | 48 | 2.7x | 0.4x | Near average | |
Capital Return | 83 | 4.57% | 2.19% | Above average | |
Momentum | 66 | — | — | Near average | |
Sentiment | 50 | — | — | Near average |
Bristol-Myers Squibb Company is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Bristol-Myers Squibb Company shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
The average price target for BMY stock saw a slight decline of 0.44% over the past 30 days, dropping from $62 to $61.73, while the number of analysts remained steady at 11. This minor adjustment reflects a state of limited caution in expectations, although the current price target remains higher than the market trading price ($54.72), indicating a potential positive valuation gap.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.